Zde se nacházíte:
Informace o publikaci
Naringenin as a dual-target modulator of RAGE-NF-κB signaling and Aβ fibrillization in Alzheimer's disease: integrated computational and experimental analyses
| Autoři | |
|---|---|
| Rok publikování | 2026 |
| Druh | Recenzovaný odborný článek |
| Časopis / Zdroj | FRONTIERS IN PHARMACOLOGY |
| Fakulta / Pracoviště MU | |
| Citace | |
| www | https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1901236/full |
| Doi | https://doi.org/10.3389/fphar.2026.1901236 |
| Klíčová slova | Alzheimer's disease; A beta aggregation; dual-target inhibitors; naringenin; neuroinflammation; RAGE signaling |
| Popis | Introduction Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by the accumulation and aggregation of beta-amyloid (A beta) and chronic neuroinflammation mediated by the receptor for advanced glycation end products (RAGE). Current therapeutic candidates targeting RAGE signaling or A beta aggregation continue to face challenges, including off-target toxicity, poor blood-brain barrier (BBB) penetration, and limited multi-target efficacy.Methods Naringenin (NAR), a naturally occurring flavanone polyphenol prioritized through structure-based virtual screening and preliminary biological evaluation, was selected for further mechanistic investigation as a potential dual-target modulator of RAGE-associated inflammatory signaling and A beta 42 fibrillization.Results Molecular docking analyses showed that NAR interacts with the RAGE interface (PDB: 6XQ3) via pi-cation interactions with ARG_98 and LYS_110 (docking score: -5.072 kcal/mol). At the A beta fibril (PDB: 2MXU), NAR showed a superior docking score than ALZ-801 (valiltramiprosate), involving hydrogen bonding and pi-pi stacking with HIS_A14 (docking score: -8.098 kcal/mol). 100 ns molecular dynamics simulations supported the stability of these binding modes, with RMSD and RMSF values within acceptable ranges. MM-GBSA rescoring indicated competitive predicted binding free energies (Delta GBind: -30.260 kcal/mol at RAGE; -220.162 kcal/mol at the fibril, compared to ALZ- 801's -214.482 kcal/mol), influenced by electrostatic and hydrophobic interactions. Per-residue energy decomposition indicated PHE_20 (-9.10 kcal/ mol) as the dominant hotspot residue, alongside ARG_98 (-4.71 kcal/mol) and LYS_52 (-3.96 kcal/mol) as key RAGE anchors. In silico ADMET profiling suggested favorable predicted BBB accessibility (score: 0.001), Caco-2 permeability, Lipinski compliance, and a more favorable predicted cardiac safety profile (hERG: 0.145) relative to V6Y. Experimentally, NAR reduced A beta 42-induced NF-kappa B activation in RAGE-positive C6 cells, protected SH-SY5Y neurons from A beta 42 toxicity, and inhibited A beta 42 fibrillization in vitro, producing non-seeding aggregates consistent with impaired fibril formation, and attenuated rotenone-induced alpha-synuclein-associated cellular stress.Discussion Collectively, these findings support further investigation of NAR as a mechanistically plausible multi-target candidate for protein aggregation and RAGE-associated inflammatory signaling in neurodegenerative disease models. |
| Související projekty: |
|